IntraBio
PrivateLast Round
VC Round
Mar 25, 2024
Total Funding Raised
$15M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
IntraBio operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a VC Round in March 2024.
IntraBio is a biopharmaceutical company that develops and commercializes innovative small-molecule therapies for rare and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IntraBio Comparables
Compare IntraBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mandos | 82% | |
| Rafael Holdings, Inc. | 81% | |
| Azafaros | 81% |
For institutional investors. Book with your work email.
IntraBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 25, 2024 | ||||
| Series C | Apr 5, 2023 | ||||
| VC Round | Nov 5, 2020 | ||||
| VC Round | Aug 20, 2018 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 2, representing 40% of headcount.
- Nov 5, 2020
$21M raised in a VC Round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueOct 5, 2026
IntraBio Inc. reports $68M in sales in 2025.
For institutional investors. Book with your work email.
IntraBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IntraBio's valuation, stock price, and market status.
Is IntraBio a public or private company?
IntraBio is a private company.
What is the current stock price of IntraBio?
IntraBio is a private company, so its shares have no public market price. Caplight tracks IntraBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IntraBio worth (valuation)?
Valuation information for IntraBio is not publicly available.
Can I buy IntraBio stock?
IntraBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IntraBio's last funding round?
IntraBio's most recent funding round was VC Round on March 25, 2024.
Who are the main investors in IntraBio?
Investor information for IntraBio is not publicly disclosed.
Will IntraBio IPO soon?
No public IPO plans have been announced for IntraBio.
How can I track IntraBio secondary market activity?
Caplight tracks bids, offers, and trades in IntraBio's shares on secondary markets.